Doseology Sciences Inc. Stock OTC Markets
Stocks
DOSEF
CA2584842033
Pharmaceuticals
OTC Markets Traded|
Real-time
OTC Markets
18:45:11 03/06/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.2500 USD | -.--% |
|
+124.42% | -28.57% |
| 1 week | +124.42% | ||
| Current month | +124.42% | ||
| 1 month | +124.42% | ||
| 3 months | -19.17% | ||
| 6 months | -52.83% | ||
| Current year | -28.57% |
| Current year | 0.01 |  | 0.68 |
| 1 year | 0.01 | | 0.68 |
| 3 years | 0.01 | | 1.83 |
| 5 years | 0.01 | | 1.83 |
| 10 years | 0.01 | | 1.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chris Jackson
CEO | Chief Executive Officer | 56 | 01/05/2025 |
| Chief Executive Officer | 47 | 13/05/2024 | |
Basin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Vice
BRD | Director/Board Member | 37 | 02/04/2021 |
Scott Reeves
BRD | Director/Board Member | 57 | 27/05/2020 |
| Director/Board Member | 55 | 13/01/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +124.42% | - | - | 844K | |
| -0.67% | +5.30% | +79.18% | +127.35% | 1,119B | |
| +0.86% | +3.94% | +52.86% | +65.19% | 651B | |
| -0.15% | +5.73% | +27.53% | +80.51% | 468B | |
| -1.38% | +4.02% | +42.52% | +42.38% | 374B | |
| -0.52% | +2.72% | +25.21% | +41.06% | 302B | |
| -1.06% | +4.76% | +2.00% | +12.65% | 259B | |
| +0.93% | +5.76% | +53.75% | +72.83% | 238B | |
| -0.53% | +2.34% | -18.53% | -53.66% | 208B | |
| +0.18% | +5.46% | +28.35% | +91.94% | 181B | |
| Average | -0.26% | +5.17% | +32.54% | +53.36% | 422.21B | |
| Weighted average by Cap. | -0.30% | +5.40% | +45.79% | +72.90% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- MOOD Stock
- DOSEF Stock
Select your edition
All financial news and data tailored to specific country editions
